Global Respiratory Syncytial Virus (RSV) Market to Expand at 29.90% CAGR by 2024 Health Articles | May 2 Teuvo Teravainen Jersey , 2016
presents this most up-to-date research on "OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) - Opportunity Analysis and Forecasts to 2024".
has announced the addition of a new research report that offers a comprehensive overview of the global respiratory syncytial virus (RSV) market and evaluates the historical as well as the current performance of this market.
The research report, titled “OpportunityAnalyzer: Respiratory Syncytial Virus (RSV) - Opportunity Analysis And Forecasts To 2024,” primarily focuses on the therapeutic landscape of the RSV infections across the world.
A human RSV is an enveloped, negative-sense, single-stranded ribonucleic acid (RNA) pneumovirus. It belongs to the paramyxoviridae family and was discovered in 1956. RSV has been identified as the most important cause of lower respiratory tract infections in infants such as bronchiolitis and pneumonia. It also causes upper respiratory tract infections such as the common cold and is a major cause of respiratory infections in elderly people in the global arena.
View Press Release Report at:
According to the market study, the global RSV market, which mainly includes the therapeutics for the treatment of RSV infections Jaccob Slavin Jersey , stood at a value of US$640 mn in 2014. Analysts expect this market to expand at an impressive CAGR of 29.90% during the period from 2014 to 2024 and reach an estimated value of US$2.3 bn by the end of the forecast period.
The key regional markets for RSV therapeutics have been identified as 7MM including the U.S., the U. K., France, Japan, Germany, Spain, and Italy in this report. Over the forecast period Brock McGinn Jersey , the U.S. is projected to lead the global market with a share of 62%. The EU 5 markets, namely the U.K., Germany, Spain, Italy, and France are likely to follow the U.S. and collectively occupy a share of 29% in the overall market during the same period.
For Sample Copy, click here:
The report further states that the launch of new and advanced prophylactic monoclonal antibodies (mAbs) with improved dosing criteria in comparison to Synagis Sebastian Aho Hurricanes Jersey , the most common prescription medication for the treatment of RSV infections, is likely to drive the growth of this market significantly across the world in the coming years. The rising demand for RSV-F vaccine by Novavax, the first adult vaccine offering protection against RSV, is also anticipated to propel this market over the next few years, notes the research study.
The research study also examines the competitive landscape of the global RSV market by analyzing the company profiles of the major enterprises operating in this market. According to it, Gilead Sciences, GlaxoSmithKline Dougie Hamilton Hurricanes Jersey , Regeneron, Johnson & Johnson, Ablynx, Novavax, and MedImmune are leading the global RSV market. Other major market participants profiled in this study are Crucell, Immunovaccine Inc., Romark Laboratories Jordan Staal Hurricanes Jersey , Spring Bank Pharmaceuticals, Ark Biosciences, Biota Pharmaceuticals, Bavarian Nordic, and Meda Pharmaceuticals.
Contact us:
Mr. Nachiket
State Tower
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website:
E : sales@
Article Tags: Global Respiratory Syncytial Justin Faulk Hurricanes Jersey , Respiratory Syncytial Virus, Global Respiratory, Respiratory Syncytial, Syncytial Virus
Bio-Implants Market- Segmentation Detailed Study with Forecast to 2024
by Metcarl · January 9, 2019
Global Bio-Implants Market: Overview
Bio-implants are widely used in organ transplantation and replacement of tissues. These are bioengineered products made up of human or animal origin and have been used in various fields of ENT leading to markedly high surgical outcomes. Emerging applications of bio-implants in different areas such as cardiovascular, neurological, orthopedic Sebastian Aho Jersey Sale , and dental surgeries and technological advancements related to the manufacturing of bio-implants have led to a steady evolution of the global bio-implants market.
View Report-
The report on global bio-implants is prepared with the help of a wide range of primary and secondary researches incorporates inputs from leading market leaders, industry strategists, biotechnology companies, and business executives. The research study offers in-depth insights into the current market status, share and size of major application segments, prominent trends, recent technological advances Dougie Hamilton Jersey Sale , and competitive dynamics. The analysis takes a closer look at the regulatory landscape in major regions and evaluates the leading strategies of market players in major regions such as North America, Europe, and Asia Pacific. The investment trends shaping the demand for key segments are covered in the study.
Global Bio-Implants Market: Trends and Opportunities
LovesGirls
Thema drucken
24.08.2019 04:50
Antworten
